Patents by Inventor Miteshgir Kanchangir GOSWAMI

Miteshgir Kanchangir GOSWAMI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESSES FOR THE PREPARATION OF ROXADUSTAT AND INTERMEDIATES THEREOF
    Publication number: 20220340532
    Abstract: The present invention provides new procedure and intermediates for the preparation of Roxadustat (1) comprising: (A) reducing a compound of formula 3?, 3? or a mixture thereof: (3?), (3?) wherein Pg is H or a OH protecting group, Ri is alkyl, aryl, or arylalkyl; R2, R3, R4, and Rs each independently represents alkyl, arylalkyl or alkenyl, or R2 and R3 and/or R4 and Rs, taken together with the nitrogen atom to which they are bonded, each independently form a ring selected from: (I), wherein R6 is H or CI-6 alkyl; R7 is Ci to C6 alkyl and X— is an anion selected from the group consisting of halide, O—SO4—R7 wherein R7 is Ci to C6 alkyl, or O—SO2-Rs wherein Rs is phenyl, tolyl, methyl or trifluoromethyl; to form a compound of formula (2?) wherein Pg is H or an OH protecting group, Ri is alkyl, aryl, or arylalkyl; and removing the Ri group and where present removing the OH protecting group; or (B) reducing a compound of formula 4?, a compound of formula 4? or a mixture thereof: (4?), (4?) wherein Pg is H or an OH
    Type: Application
    Filed: August 6, 2020
    Publication date: October 27, 2022
    Inventors: Parven Kumar Luthra, Suhail Ahmad, Neval Kishor, Miteshgir Kanchangir Goswami, Alok Singh, Chandrasekhar Sinha, Syed Aziz Imam Quadri, Prashant Shankar Joshi, Sadanand Hardeo Maurya
  • Processes for the preparation of sofosbuvir and intermediates thereof
    Patent number: 10676498
    Abstract: The present disclosure provides procedures and intermediates for the preparation of Sofosbuvir, comprising the step of reacting a compound of formula 2: wherein R1 and R2 can independently be hydrogen or halogen, provided that at least one of R1 and R2 is a halogen.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: June 9, 2020
    Assignee: Teva Pharmaceuticals International GmbH
    Inventors: Vinod Kumar Kansal, Dhirenkumar Natvarial Mistry, Srinivas Achanta, Sundaraselvan Ariyamuthu, Miteshgir Kanchangir Goswami, Venkata Subbarao Yazali
  • IMPROVED PROCESSES FOR THE PREPARATION OF SOFOSBUVIR AND INTERMEDIATES THEREOF
    Publication number: 20190218243
    Abstract: The present disclosure provides procedures and intermediates for the preparation of Sofosbuvir, comprising the step of reacting a compound of formula 2: wherein R1 and R2 can independently be hydrogen or halogen, provided that at least one of R1 and R2 is a halogen.
    Type: Application
    Filed: June 2, 2016
    Publication date: July 18, 2019
    Inventors: Vinod Kumar KANSAL, Dhirenkumar Natvarial MISTRY, Srinivas ACHANTA, Sundaraselvan ARIYAMUTHU, Miteshgir Kanchangir GOSWAMI, Venkata Subbarao YAZALI